Integrated BioPharma, Inc. (INBP) Stock
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Integrated BioPharma, Inc.
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Integrated BioPharma, Inc. is headquartered in US.
Integrated BioPharma, Inc. (INBP) stock trades at $0.16 with a market capitalization of $5.09M. The stock is valued at a price-to-earnings (P/E) ratio of -3.08, price-to-book of 0.27, price-to-sales of 0.11. Over the past 52 weeks the stock has ranged between $0.14 and $0.42, and currently trades 61.9% below its 52-week high.
On profitability, Integrated BioPharma, Inc. generates a return on equity (ROE) of -8.32%, return on capital employed of -5.90%, an operating margin of -2.58%, a net profit margin of -3.43%.
Official website: ir.ibiopharma.com